The Chemical Entities of Biological Interest (ChEBI) ontology is downloaded weekly from EMBL-EBI at http://www.ebi.ac.uk/chebi/. The data is made available under the Creative Commons License (CC BY 3.0, http://creativecommons.org/licenses/by/3.0/). For more information see: Degtyarenko et al. (2008) ChEBI: a database and ontology for chemical entities of biological interest. Nucleic Acids Res. 36, D344–D350.
corosolic acid inhibits the reaction [Doxorubicin results in increased expression of BAX protein]; corosolic acid inhibits the reaction [Ethanol results in increased expression of BAX protein]; PRKAA2 protein promotes the reaction [corosolic acid inhibits the reaction [Doxorubicin results in increased expression of BAX protein]]; TFEB protein promotes the reaction [corosolic acid inhibits the reaction [Doxorubicin results in increased expression of BAX protein]] corosolic acid results in increased expression of BAX mRNA; corosolic acid results in increased expression of BAX protein
corosolic acid results in decreased expression of BCL2 mRNA; corosolic acid results in decreased expression of BCL2 protein corosolic acid inhibits the reaction [Doxorubicin results in decreased expression of BCL2 protein]; PRKAA2 protein promotes the reaction [corosolic acid inhibits the reaction [Doxorubicin results in decreased expression of BCL2 protein]]; TFEB protein promotes the reaction [corosolic acid inhibits the reaction [Doxorubicin results in decreased expression of BCL2 protein]]
corosolic acid inhibits the reaction [Ethanol results in increased cleavage of CASP3 protein] corosolic acid results in decreased expression of CASP3 mRNA corosolic acid results in increased cleavage of CASP3 protein corosolic acid inhibits the reaction [Doxorubicin results in increased expression of CASP3 protein modified form]
corosolic acid analog inhibits the reaction [Tetradecanoylphorbol Acetate results in increased expression of CXCL2 mRNA]; corosolic acid inhibits the reaction [Tetradecanoylphorbol Acetate results in increased expression of CXCL2 mRNA]
corosolic acid analog inhibits the reaction [Tetradecanoylphorbol Acetate results in increased expression of CXCL1 mRNA]; corosolic acid inhibits the reaction [Tetradecanoylphorbol Acetate results in increased expression of CXCL1 mRNA]
corosolic acid inhibits the reaction [Doxorubicin results in increased expression of CYBB protein]; PRKAA2 protein promotes the reaction [corosolic acid inhibits the reaction [Doxorubicin results in increased expression of CYBB protein]] corosolic acid inhibits the reaction [Doxorubicin results in increased expression of CYBB mRNA]; corosolic acid inhibits the reaction [Doxorubicin results in increased expression of CYBB protein]
corosolic acid analog inhibits the reaction [Tetradecanoylphorbol Acetate results in increased expression of IL17A mRNA]; corosolic acid inhibits the reaction [Tetradecanoylphorbol Acetate results in increased expression of IL17A mRNA]
corosolic acid analog inhibits the reaction [Tetradecanoylphorbol Acetate results in decreased expression of JUN protein]; corosolic acid analog inhibits the reaction [Tetradecanoylphorbol Acetate results in increased phosphorylation of JUN protein]; corosolic acid inhibits the reaction [Tetradecanoylphorbol Acetate results in increased phosphorylation of JUN protein]
corosolic acid inhibits the reaction [Doxorubicin results in decreased expression of LAMP2 protein] corosolic acid inhibits the reaction [Doxorubicin results in decreased expression of LAMP2 protein]; TFEB protein promotes the reaction [corosolic acid inhibits the reaction [Doxorubicin results in decreased expression of LAMP2 protein]]
corosolic acid results in increased expression of NFKBIA mRNA corosolic acid results in increased expression of and results in decreased phosphorylation of NFKBIA protein
PRKAA2 gene mutant form results in decreased susceptibility to corosolic acid PRKAA2 protein promotes the reaction [corosolic acid inhibits the reaction [Doxorubicin results in decreased expression of BCL2 protein]]; PRKAA2 protein promotes the reaction [corosolic acid inhibits the reaction [Doxorubicin results in increased expression of BAX protein]]; PRKAA2 protein promotes the reaction [corosolic acid inhibits the reaction [Doxorubicin results in increased expression of CYBB protein]]
corosolic acid analog inhibits the reaction [Tetradecanoylphorbol Acetate results in increased expression of PTGS2 mRNA]; corosolic acid analog inhibits the reaction [Tetradecanoylphorbol Acetate results in increased expression of PTGS2 protein]; corosolic acid inhibits the reaction [Tetradecanoylphorbol Acetate results in increased expression of PTGS2 mRNA]; corosolic acid inhibits the reaction [Tetradecanoylphorbol Acetate results in increased expression of PTGS2 protein]
corosolic acid results in decreased expression of RELA mRNA corosolic acid results in decreased expression of and affects the localization of RELA protein
corosolic acid inhibits the reaction [Doxorubicin results in increased expression of SQSTM1 protein] corosolic acid inhibits the reaction [Doxorubicin results in increased expression of SQSTM1 protein]; TFEB protein promotes the reaction [corosolic acid inhibits the reaction [Doxorubicin results in increased expression of SQSTM1 protein]]
corosolic acid analog inhibits the reaction [Tetradecanoylphorbol Acetate results in increased phosphorylation of SRC protein]; corosolic acid inhibits the reaction [Tetradecanoylphorbol Acetate results in increased phosphorylation of SRC protein]
corosolic acid analog inhibits the reaction [Tetradecanoylphorbol Acetate results in increased phosphorylation of STAT3 protein]; corosolic acid inhibits the reaction [Tetradecanoylphorbol Acetate results in increased phosphorylation of STAT3 protein]
corosolic acid analog inhibits the reaction [Tetradecanoylphorbol Acetate results in decreased phosphorylation of STK11 protein]; corosolic acid inhibits the reaction [Tetradecanoylphorbol Acetate results in decreased phosphorylation of STK11 protein]
TFEB protein results in increased susceptibility to corosolic acid TFEB protein promotes the reaction [corosolic acid inhibits the reaction [Doxorubicin results in decreased expression of BCL2 protein]]; TFEB protein promotes the reaction [corosolic acid inhibits the reaction [Doxorubicin results in decreased expression of LAMP2 protein]]; TFEB protein promotes the reaction [corosolic acid inhibits the reaction [Doxorubicin results in increased expression of BAX protein]]; TFEB protein promotes the reaction [corosolic acid inhibits the reaction [Doxorubicin results in increased expression of SQSTM1 protein]]
corosolic acid analog inhibits the reaction [Tetradecanoylphorbol Acetate results in increased expression of VEGFA mRNA]; corosolic acid inhibits the reaction [Tetradecanoylphorbol Acetate results in increased expression of VEGFA mRNA]